From August to October 2026, methionine supply saw several changes, including a month-on-month decline in imports, production line shutdowns for modification, and factories resuming production or planning maintenance. An industry market summary dated November 2, 2026, reflects these developments but provides no new policies, regulations, or trade rules. For trade and procurement operations that depend on methionine supply, production line adjustments and maintenance schedules warrant attention. Their actual impact remains subject to subsequent delivery conditions.

Declining Imports and Factory Production Schedules

An industry market summary dated November 2, 2026, shows that domestic methionine imports in August 2026 totaled 9,800 metric tons, up 3.7% year on year and down 35% month on month.

On the supply chain side, CJ Malaysia’s 80,000-ton methionine production line shut down at the end of August. After the shutdown, it will not resume biological methionine production and is scheduled to be converted to produce other amino acid products. Evonik’s methionine plant in Singapore resumed normal production on September 22. Adisseo’s methionine plant in Nanjing is scheduled for maintenance in October.

How Production Line Adjustments Affect Procurement and Delivery Assessments

Traders and Distributors Should Verify Supply Arrangements

The analysis suggests that CJ’s decision not to resume biological methionine production may affect how relevant trading companies and distributors assess their existing supply arrangements. Companies can confirm available products, quantities, and delivery dates with suppliers, and monitor how production schedules at other plants may affect specific orders. The input does not specify any changes to existing contracts or order fulfillment, so it does not support the conclusion that delivery disruptions have occurred.

Procurement Should Distinguish Between Supply Sources

From a procurement perspective, the month-on-month decline in August imports, together with production schedules at different plants, may make it more difficult for companies to assess procurement timing and supply sources. Buyers can verify available quantities and estimated lead times with each supplier and assess whether procurement plans need to be adjusted. Monthly fluctuations in import volumes alone are not sufficient to indicate future supply or price trends.

Downstream Producers Should Assess Alternatives

The analysis suggests that companies relying on methionine as a raw material may need to consider how supply adjustments could affect their production schedules. If considering a change of supplier or product, they can check product documentation and suitability in advance and validate alternatives against their actual needs. The input does not specify whether alternative products are available or suitable.

Check Orders and Production Line Progress

Confirm Existing Orders and Delivery Dates

Relevant companies can confirm the quantities, delivery dates, and supply arrangements for outstanding orders with their suppliers, paying particular attention to whether production line shutdowns for modification or factory maintenance affect their own orders. If procurement plans need to be adjusted, feasible options can be assessed based on the confirmed information.

Monitor the Resumption of Production and Maintenance Progress

Evonik’s Singapore plant resumed normal production on September 22, while Adisseo’s Nanjing plant is scheduled for maintenance in October. Companies can still verify how these arrangements affect the supply of specific products and order deliveries. The input does not provide the actual progress or completion date of the maintenance at the Nanjing plant.

Check Alternative Products and Documentation

For supply sources under consideration, buyers can check product specifications, quality documentation, and contractual terms, and assess alternative products based on their intended use. These checks are procurement recommendations and do not indicate that this update introduces new certification or compliance requirements.

This Appears to Be a Change in Supply Arrangements, Not the Implementation of New Rules

The key points in this update are changes in import data and company production schedules. The input does not confirm any new policies, regulations, standards, certifications, or trade rules, so it should not be described as a change in rules or the implementation of new regulatory requirements.

Further assessment will depend on the progress of CJ’s production line conversion, the actual maintenance situation at Adisseo’s Nanjing plant, and the specific arrangements companies make for orders and deliveries. If formal rule changes related to methionine trade or product requirements emerge, they should be verified against reliable information.

Adjust Procurement Assessments Based on Actual Supply Information

The month-on-month decline in August imports and changes to production schedules at some plants give traders and buyers reason to review their supply plans, but the available information is insufficient to determine the overall market impact. For now, these developments are best treated as supply chain changes requiring ongoing verification, with decisions based on specific contracts, product documentation, and delivery updates.

Information Basis and Further Verification

This article presents an analysis based on the news headline, event date, and event summary provided by the user. The input does not include a specific link to an official source, so the relevant data, factory arrangements, and subsequent developments should continue to be verified.

Further checks can include company announcements, information from customs or trade authorities, and industry sources, as well as verification of factory operations, trade deliveries, and industry feedback. Any changes to relevant policies or certification requirements should also be confirmed against official publications.